131 related articles for article (PubMed ID: 25017047)
1. Estrogen receptor α promotes non-amyloidogenic processing of platelet amyloid precursor protein via the MAPK/ERK pathway.
Shi C; Zhu X; Wang J; Long D
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():280-5. PubMed ID: 25017047
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rg1 promotes nonamyloidgenic cleavage of APP via estrogen receptor signaling to MAPK/ERK and PI3K/Akt.
Shi C; Zheng DD; Fang L; Wu F; Kwong WH; Xu J
Biochim Biophys Acta; 2012 Apr; 1820(4):453-60. PubMed ID: 22178929
[TBL] [Abstract][Full Text] [Related]
3. Estrogenic effect of ginsenoside Rg1 on APP processing in post-menopausal platelets.
Shi C; Na N; Zhu X; Xu J
Platelets; 2013; 24(1):51-62. PubMed ID: 22372534
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rd promotes non-amyloidogenic pathway of amyloid precursor protein processing by regulating phosphorylation of estrogen receptor alpha.
Yan X; Hu G; Yan W; Chen T; Yang F; Zhang X; Zhao G; Liu J
Life Sci; 2017 Jan; 168():16-23. PubMed ID: 27825720
[TBL] [Abstract][Full Text] [Related]
5. Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695.
Peng Y; Lee DY; Jiang L; Ma Z; Schachter SC; Lemere CA
Neuroscience; 2007 Dec; 150(2):386-95. PubMed ID: 17945434
[TBL] [Abstract][Full Text] [Related]
6. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
eNeuro; 2017; 4(2):. PubMed ID: 28374012
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic approaches to Alzheimer's disease through stimulating of non-amyloidogenic processing of amyloid precursor protein.
Wang YQ; Qu DH; Wang K
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2389-403. PubMed ID: 27338066
[TBL] [Abstract][Full Text] [Related]
8. Octyl gallate markedly promotes anti-amyloidogenic processing of APP through estrogen receptor-mediated ADAM10 activation.
Zhang SQ; Sawmiller D; Li S; Rezai-Zadeh K; Hou H; Zhou S; Shytle D; Giunta B; Fernandez F; Mori T; Tan J
PLoS One; 2013; 8(8):e71913. PubMed ID: 23977176
[TBL] [Abstract][Full Text] [Related]
9. AMPA receptor activation promotes non-amyloidogenic amyloid precursor protein processing and suppresses neuronal amyloid-β production.
Hoey SE; Buonocore F; Cox CJ; Hammond VJ; Perkinton MS; Williams RJ
PLoS One; 2013; 8(10):e78155. PubMed ID: 24205136
[TBL] [Abstract][Full Text] [Related]
10. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
[TBL] [Abstract][Full Text] [Related]
11. Estrogen-induced cell signalling in a cellular model of Alzheimer's disease.
Goodenough S; Schäfer M; Behl C
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):301-5. PubMed ID: 12711016
[TBL] [Abstract][Full Text] [Related]
12. Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro.
Mei Z; Zhang F; Tao L; Zheng W; Cao Y; Wang Z; Tang S; Le K; Chen S; Pi R; Liu P
Neurosci Lett; 2009 Mar; 452(2):90-5. PubMed ID: 19154776
[TBL] [Abstract][Full Text] [Related]
13. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.
España J; Giménez-Llort L; Valero J; Miñano A; Rábano A; Rodriguez-Alvarez J; LaFerla FM; Saura CA
Biol Psychiatry; 2010 Mar; 67(6):513-21. PubMed ID: 19664757
[TBL] [Abstract][Full Text] [Related]
14. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
Corbett GT; Gonzalez FJ; Pahan K
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
[TBL] [Abstract][Full Text] [Related]
15. Acute Effects of Muscarinic M1 Receptor Modulation on AβPP Metabolism and Amyloid-β Levels in vivo: A Microdialysis Study.
Welt T; Kulic L; Hoey SE; McAfoose J; Späni C; Chadha AS; Fisher A; Nitsch RM
J Alzheimers Dis; 2015; 46(4):971-82. PubMed ID: 25881909
[TBL] [Abstract][Full Text] [Related]
16. Amyloid precursor protein is required for in vitro platelet adhesion to amyloid peptides and potentiation of thrombus formation.
Visconte C; Canino J; Guidetti GF; Zarà M; Seppi C; Abubaker AA; Pula G; Torti M; Canobbio I
Cell Signal; 2018 Dec; 52():95-102. PubMed ID: 30172024
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1alpha stimulates non-amyloidogenic pathway by alpha-secretase (ADAM-10 and ADAM-17) cleavage of APP in human astrocytic cells involving p38 MAP kinase.
Bandyopadhyay S; Hartley DM; Cahill CM; Lahiri DK; Chattopadhyay N; Rogers JT
J Neurosci Res; 2006 Jul; 84(1):106-18. PubMed ID: 16724341
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin-induced activation of Alzheimer's alpha secretase is resistant to standard inhibitors of protein phosphorylation-regulated ectodomain shedding.
Parvathy S; Ehrlich M; Pedrini S; Diaz N; Refolo L; Buxbaum JD; Bogush A; Petanceska S; Gandy S
J Neurochem; 2004 Aug; 90(4):1005-10. PubMed ID: 15287907
[TBL] [Abstract][Full Text] [Related]
19. Activity requires soluble amyloid precursor protein alpha to promote neurite outgrowth in neural stem cell-derived neurons via activation of the MAPK pathway.
Gakhar-Koppole N; Hundeshagen P; Mandl C; Weyer SW; Allinquant B; Müller U; Ciccolini F
Eur J Neurosci; 2008 Sep; 28(5):871-82. PubMed ID: 18717733
[TBL] [Abstract][Full Text] [Related]
20. Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease.
Tang K; Hynan LS; Baskin F; Rosenberg RN
J Neurol Sci; 2006 Jan; 240(1-2):53-8. PubMed ID: 16256140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
